CN Patent

CN104244945A — 用于治疗hcv的方法

Assigned to Gilead Sciences Inc · Expires 2014-12-24 · 11y expired

What this patent protects

本发明涉及用于治疗丙肝病毒感染的治疗分子的组合。本发明涉及方法、用途、给药方案和组合物。

USPTO Abstract

本发明涉及用于治疗丙肝病毒感染的治疗分子的组合。本发明涉及方法、用途、给药方案和组合物。

Drugs covered by this patent

Patent Metadata

Patent number: CN104244945A
Jurisdiction: CN
Classification: —
Expires: 2014-12-24
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.